Pharma IQ | 10/27/2014
As biotech/emerging companies develop and their assets/operations approach commercial maturity we see a change in the skill mix sought by Chairs.
o It is unsurprising that 70% of those surveyed say that knowledge of the Life Sciences industry is essential.
o In recent years it has become apparent to us that commercialisation experience is a crucial part of the skill mix for a Life Sciences Board- 58% of our survey agrees.
o As open Innovation rises and in-house generated pipelines con...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
SmartLab Exchange USA 2025
08 - 09 April, 2025
Le Méridien, Fort Lauderdale, Florida, USA
Register Now |
View Agenda |
Learn More